Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide

Blood

Volumn 97, Issue 5, 2001, Pages 1514-1516

  Unnikrishnan, Dilip ^b   Dutcher, Janice P ^a   Varshneya, Nikita ^b   Lucariello, Richard ^b   Api, Marietta ^b   Garl, Susan ^b   Wiernik, Peter H ^b   Chiaramida, Salvatore ^b  

^a Our Lady of Mercy Cancer Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BRETYLIUM; LIDOCAINE; MAGNESIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TORSADE DES POINTES; TREATMENT FAILURE;

EID: 0035283137     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1514     Document Type: Article

References (20)

1. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
2. Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia
3. Arsenic trioxide and melarsoprolol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML/RAR-alpha independent manner
4. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia
5. Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL), II: Clinical efficacy and pharmacokinetics in relapsed patients
6. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukemia
7. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
8. Phase II trial of arsenic trioxide in patients with relapsed/refractory acute myeloid leukemia, blast crisis of CML, or myelodysplasia
9. U.S. Multicenter trial of arsenic trioxide in acute promyelocytic leukemia
10. Torsades de pointes in two patients on treatment with arsenic trioxide
11. Arsenic-induced atypical ventricular tachycardia
12. The electrocardiogram in acute arsenic poisoning
13. Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndromes
14. The role of metals in carcinogenesis: Biochemistry and metabolism
15. The long QT syndrome
16. Arsenic speciation in human organs following fatal arsenic trioxide poisoning: A case report
17. Long QT syndromes and torsades de pointes
18. Multiple mechanisms in the long-QT syndrome
19. Treatment of torsades de pointes with magnesium sulfate
20. Comparison of the effects of taurine and magnesium on electrical characteristics of artificial and natural membranes, V: Study on the human amnion of the antagonism between magnesium, taurine and polluting metals